Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03905421 · ClinicalTrials.gov registry record
Quality of Life Assessed With the PAH SYMPACT Questionnaire
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 390
- Enrollment target
NCT03905421: Completed study, sponsored by Mayo Clinic.
NCT03905421 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 390 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03905421 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 390 participants
- Enrollment target
Study Summary
Researchers are evaluating quality of life in pulmonary hypertension subjects using the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT) Questionnaire and assessing the questionnaires' performance with regard to relationship to other markers of disease severity, response to treatment, and outcome in a clinical practice setting.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 390 participants |
| Start Date | 2019-03-06 |
| Est. Completion | 2024-01-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03905421
The ClinicalTrials.gov registry entry for NCT03905421 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 390 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03905421 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03905421 about?
NCT03905421 is a clinical study titled "Quality of Life Assessed With the PAH SYMPACT Questionnaire". Researchers are evaluating quality of life in pulmonary hypertension subjects using the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT) Questionnaire and assessing the questionnaires' performance with regard to relationship to other markers of disease severity, response to treatmen...
What is the current status of trial NCT03905421?
This trial is currently completed. The enrollment target is 390 participants. The study started on 2019-03-06. Estimated completion is 2024-01-22.
Who is sponsoring clinical trial NCT03905421?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.